Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of BIIL 284 BS on Prednisone PK in Healthy Males
NCT02268149Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 2000
- Primary completion
- Jul 2000
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial in cystic fibrosis (CF) and rheumatoid arthritis (RA) comparing BIIL 284 BS + Prednisone with Placebo + Prednisone (2 arms). Primary endpoints: Area under the concentration-time curve, Maximum measured concentration and 5 more. Started Apr 2000; status: completed.
02
Drugs
amelubant
03
Conditions
cystic fibrosis (CF)rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02268149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02268149.